Drug Eluting Stent Clinical Trial
Official title:
A Prospective, Multicenter, Single-Arm, Objective Performance Criteria-Clinical Study: Evaluation for Safety and Efficacy of Firehorus Rapamycin Target Eluting Vertebral Artery Stent System in Clinical Application
This clinical trial uses a prospective, multicenter, single-arm, objective performance criteria-design, aiming to evaluate the safety and effectiveness of Firehorus Rapamycin Target Eluting Vertebral Artery Stent System .
This clinical trial uses a prospective, multicenter, single-arm, objective performance criteria-design, aiming to evaluate the safety and effectiveness of Firehorus Rapamycin Target Eluting Vertebral Artery Stent System (hereinafter referred to as Firehorus) in clinical application, in which 6 clinical trial centers are selected to employ Firehorus to treat subjects who are screened according to inclusion and exclusion criteria defined in this protocol. During this clinical trial, postoperative immediate success rate of stent implantation is recorded after surgery; DSA angiographic follow up is performed at 6 months (±30 days) after surgery; in-stent restenosis rate (stenosis degree ≥50%) is evaluated; and clinical follow up is performed at 30 days (±7d), 6 months (±30d), 12 months (±30d) after surgery; in order to evaluate the safety and effectiveness of Firehorus in clinical application. Each subject is expected to participate in the trial for 12 months (±30d) from entering the group to completion of follow up. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06186024 -
A PROSPECTIVE, MULTICENTER, SINGLE-ARM TRIAL FOR THE NEW SIZES OF BRIDGE STENTS FOR VERTEBRAL ARTERY STENOSIS: Bridge-MAX
|
N/A | |
Active, not recruiting |
NCT03999983 -
Vertebral Artery Origin Treatment Via Endovascular Techniques Registry (VOTER)
|
||
Recruiting |
NCT03504657 -
Drug-coated Balloon Angioplasty for Patients With Symptomatic Vertebral Artery Stenosis
|
Phase 2 | |
Completed |
NCT03201432 -
Drug Eluting Stents Versus Bare Metal Stents for Treatment of Symptomatic Extracranial Vertebral Artery Stenosis
|
Phase 2/Phase 3 | |
Recruiting |
NCT05644314 -
Efficacy of Drug-Eluting Vertebral Artery Stenting Treatment for Atherosclerotic Vertebral Arteries Stenosis
|
N/A | |
Recruiting |
NCT06301776 -
A Prospective, Experimental, Multicenter, Open-label, Randomized, Controlled Trial of 3-month Dual Antiplatelet Therapy Followed by Ticagrelor Versus 6-month Dual Antiplatelet Therapy Followed by Ticagrelor After Implanting Bridge
|
N/A | |
Recruiting |
NCT05885932 -
Drug-eluting Stenting Versus Medical Treatment for Extracranial Vertebral Artery Stenosis
|
N/A | |
Recruiting |
NCT00172458 -
Clinical Results and Restenosis Analysis of Symptomatic Ostial Vertebral Artery Stenosis Treated With Tubular Coronary Stents
|
N/A |